JORDAN MASON: Open Payments
NPI 1194507657 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,531 in 98 payments from 17 companies in 2025. Trend: 2023 $413 · 2024 $2,327 · 2025 $2,531
Food & beverage: $2,196Education: $335
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $322 |
| GENZYME CORPORATION | 10 | $305 |
| Regeneron Healthcare Solutions, Inc. | 8 | $251 |
| UCB, Inc. | 10 | $251 |
| LEO Pharma Inc. | 10 | $226 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $194 |
| Arcutis Biotherapeutics, Inc. | 3 | $171 |
| Lilly USA, LLC | 8 | $170 |
| ABBVIE INC. | 8 | $151 |
| Amgen Inc. | 7 | $138 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Zoryve, EBGLYSS, ADBRY, OTEZLA, SKYRIZI.
Industry payments across GA — which companies pay providers there.
